Detalhe da pesquisa
1.
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
J Neuroinflammation
; 13(1): 169, 2016 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27357191
2.
Pancreastatin predicts survival in neuroendocrine tumors.
Ann Surg Oncol
; 21(9): 2971-80, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24752611
3.
GIPR expression in gastric and duodenal neuroendocrine tumors.
J Surg Res
; 190(2): 587-93, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24565507
4.
Auranofin Inhibition of Thioredoxin Reductase Sensitizes Lung Neuroendocrine Tumor Cells (NETs) and Small Cell Lung Cancer (SCLC) Cells to Sorafenib as well as Inhibiting SCLC Xenograft Growth.
bioRxiv
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37215042
5.
Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers.
Radiat Res
; 201(1): 35-47, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37989124
6.
Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.
Ann Surg Oncol
; 20 Suppl 3: S739-S746, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114056
7.
Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
J Neuroinflammation
; 14(1): 157, 2017 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28778207
8.
Management of neuroendocrine tumors in children, adolescents, and young adults.
J Pediatr Hematol Oncol
; 34 Suppl 2: S64-8, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22525409
9.
Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy.
Cancers (Basel)
; 14(8)2022 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454817
10.
Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.
Bioorg Med Chem Lett
; 21(19): 5757-61, 2011 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21873053
11.
Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.
Pediatr Blood Cancer
; 56(1): 50-7, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21108439
12.
Potential for Increasing Uptake of Radiolabeled 68Ga-DOTATOC and 123I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat.
Cancer Biother Radiopharm
; 36(8): 632-641, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34252288
13.
Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors.
J Nucl Med
; 62(9): 1274-1277, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33517327
14.
Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients.
Cancers (Basel)
; 13(24)2021 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34944910
15.
A DOTA-peptide conjugate by copper-free click chemistry.
Bioorg Med Chem Lett
; 20(16): 4805-7, 2010 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20630750
16.
Evolution of Neuroendocrine Tumor Therapy.
Surg Oncol Clin N Am
; 29(2): 145-163, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32151353
17.
Prospective Analysis of the Impact of 68Ga-DOTATOC Positron Emission Tomography-Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine Tumors.
Pancreas
; 49(8): 1033-1036, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32769854
18.
The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation.
J Mol Neurosci
; 37(2): 160-7, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18663606
19.
Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma.
Front Oncol
; 9: 53, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30854332
20.
ECM1 expression in thyroid tumors--a comparison of real-time RT-PCR and IHC.
J Surg Res
; 149(1): 62-8, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18374945